Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ananth

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Neuropsychobiology|January 1, 1993
Rapid cycling patients: conceptual and etiological factorsJ Ananth, M Wohl, V Ranganath, et al.
Current Pharmaceutical Design|July 30, 2004
The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptomsK Burgyone, K Aduri, J Ananth, et al.
Psychosomatics|January 1, 1975
Doxepin in the treatment of obsessive compulsive neurosisJ Ananth, L Solyom, C Solyom, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 1, 1983
Tardive dyskinesia in an outpatient population: prevalence and predisposing factorsR Yassa, J Ananth, S Cordozo, et al.
Journal of Psychiatry & Neuroscience : JPN|January 5, 2002
How do the atypical antipsychotics work?J Ananth, K S Burgoyne, R Gadasalli, et al.
Indian Journal of Psychiatry|July 12, 2011
Abuse of monoamine oxidase inhibitorsJ Ananth, J R Swartz, R Gadasally, et al.
The Journal of Clinical Psychiatry|July 1, 1987
Midazolam in acute psychotic patients with hyperarousalR Mendoza, A H Djenderedjian, J Adams, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 1993
Is the routine CT head scan justified for psychiatric patients? A prospective studyJ Ananth, R Gamal, M Miller, et al.
Current Pharmaceutical Design|July 30, 2004
Rehabilitation of schizophrenic patientsS Gunatilake, J Ananth, S Parameswaran, et al.
Psychopharmacology|October 18, 2001
Are African American patients at a higher risk for olanzapine-induced glucose intolerance?J Ananth, S Gunatilake, S Aquino, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Neuropsychobiology|January 1, 1993
Rapid cycling patients: conceptual and etiological factorsJ Ananth, M Wohl, V Ranganath, et al.
Current Pharmaceutical Design|July 30, 2004
The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptomsK Burgyone, K Aduri, J Ananth, et al.
Psychosomatics|January 1, 1975
Doxepin in the treatment of obsessive compulsive neurosisJ Ananth, L Solyom, C Solyom, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 1, 1983
Tardive dyskinesia in an outpatient population: prevalence and predisposing factorsR Yassa, J Ananth, S Cordozo, et al.
Journal of Psychiatry & Neuroscience : JPN|January 5, 2002
How do the atypical antipsychotics work?J Ananth, K S Burgoyne, R Gadasalli, et al.
Indian Journal of Psychiatry|July 12, 2011
Abuse of monoamine oxidase inhibitorsJ Ananth, J R Swartz, R Gadasally, et al.
The Journal of Clinical Psychiatry|July 1, 1987
Midazolam in acute psychotic patients with hyperarousalR Mendoza, A H Djenderedjian, J Adams, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 1993
Is the routine CT head scan justified for psychiatric patients? A prospective studyJ Ananth, R Gamal, M Miller, et al.
Current Pharmaceutical Design|July 30, 2004
Rehabilitation of schizophrenic patientsS Gunatilake, J Ananth, S Parameswaran, et al.
Psychopharmacology|October 18, 2001
Are African American patients at a higher risk for olanzapine-induced glucose intolerance?J Ananth, S Gunatilake, S Aquino, et al.
Pageof 14